Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?

被引：45

作者：

Butler, P. C. ^{[1
]}

Matveyenko, A. V. ^{[1
]}

Dry, S. ^{[1
]}

Bhushan, A. ^{[1
]}

Elashoff, R. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Larry Hillblom Islet Res Ctr, Los Angeles, CA 90024 USA

来源：

DIABETOLOGIA | 2010年 / 53卷 / 01期

关键词：

GLP-1; Glucagon-like peptide-1; Pancreatic cancer; Pancreatitis; Type; 2; diabetes; HEREDITARY PANCREATITIS; EXENATIDE; RISK; MECHANISMS; GENE; SITAGLIPTIN; EXPRESSION; MUTATIONS; DISEASE; MODIFY;

D O I：

10.1007/s00125-009-1591-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 6

页数：6

共 38 条

[1]

[Anonymous], SIT MARK JAN JAN AC

[2] Notch signalling controls pancreatic cell differentiation [J].

Apelqvist, Å ;

Li, H ;

Sommer, L ;

Beatus, P ;

Anderson, DJ ;

Honjo, T ;

de Angelis, MH ;

Lendahl, U ;

Edlund, H .

NATURE, 1999, 400 (6747) :877-881

[3] EXENATIDE-INDUCED ACUTE PANCREATITIS [J].

Ayoub, Walaa A. ;

Kumar, Ashok A. ;

Naguib, Hossam S. ;

Taylor, Harris C. .

ENDOCRINE PRACTICE, 2010, 16 (01) :80-83

[4] Mechanisms of parenchymal injury and signaling pathways in ectatic ducts of chronic pancreatitis: implications for pancreatic carcinogenesis [J].

Bhanot, Umesh K. ;

Moeller, Peter .

LABORATORY INVESTIGATION, 2009, 89 (05) :489-497

[5] Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) [J].

Buse, John B. ;

Rosenstock, Julio ;

Sesti, Giorgio ;

Schmidt, Wolfgang E. ;

Montanya, Eduard ;

Brett, Jason H. ;

Zychma, Marcin ;

Blonde, Lawrence .

LANCET, 2009, 374 (9683) :39-47

[6] Pancreatic duct replication is increased with obesity and type 2 diabetes in humans [J].

Butler, A. E. ;

Galasso, R. ;

Matveyenko, A. ;

Rizza, R. A. ;

Dry, S. ;

Butler, P. C. .

DIABETOLOGIA, 2010, 53 (01) :21-26

[7] Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study [J].

Crous-Bou, Marta ;

Porta, Miquel ;

Morales, Eva ;

Lopez, Tomas ;

Carrato, Alfredo ;

Puigdomenech, Elisa ;

Real, Francisco X. .

CANCER CAUSES & CONTROL, 2009, 20 (05) :591-599

[8]

Cure P, 2008, NEW ENGL J MED, V358, P1969, DOI 10.1056/NEJMc0707137

[9] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes [J].

Currie, C. J. ;

Poole, C. D. ;

Gale, E. A. M. .

DIABETOLOGIA, 2009, 52 (09) :1766-1777

[10] Exenatide (Exendin-4)-induced pancreatitis - A case report [J].

Denker, PS ;

Dimarco, PE .

DIABETES CARE, 2006, 29 (02) :471-471

← 1 2 3 4 →